These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 7759159

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
    Hoffmann J, Bohlmann R, Heinrich N, Hofmeister H, Kroll J, Künzer H, Lichtner RB, Nishino Y, Parczyk K, Sauer G, Gieschen H, Ulbrich HF, Schneider MR.
    J Natl Cancer Inst; 2004 Feb 04; 96(3):210-8. PubMed ID: 14759988
    [Abstract] [Full Text] [Related]

  • 24. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7.
    Butler WB, Fontana JA.
    Cancer Res; 1992 Nov 15; 52(22):6164-7. PubMed ID: 1423259
    [Abstract] [Full Text] [Related]

  • 25. Compared effects of GnRH analogs and 4-hydroxytamoxifen on growth and steroid receptors in antiestrogen sensitive and resistant MCF-7 breast cancer cell sublines.
    Néri C, Berthois Y, Schatz B, Drieu K, Martin PM.
    Breast Cancer Res Treat; 1990 Feb 15; 15(2):85-93. PubMed ID: 2138918
    [Abstract] [Full Text] [Related]

  • 26. Differential effects of estrogen, tamoxifen and the pure antiestrogen ICI 182,780 in human drug-resistant leukemia cell lines.
    Zalcberg JR, Hu XF, Ching M, Wakeling A, Wall DM, Marschner IC, de Luise M.
    Cancer Chemother Pharmacol; 1993 Feb 15; 33(2):123-9. PubMed ID: 7903222
    [Abstract] [Full Text] [Related]

  • 27. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS.
    Mol Endocrinol; 1996 Mar 15; 10(3):230-42. PubMed ID: 8833652
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Estrogen induces death of tamoxifen-resistant MCF-7 cells: contrasting effect of the estrogen receptor downregulator fulvestrant.
    Planas-Silva MD, Waltz PK, Kilker RL.
    J Steroid Biochem Mol Biol; 2006 Mar 15; 98(4-5):193-8. PubMed ID: 16464573
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo.
    Vickers PJ, Dickson RB, Shoemaker R, Cowan KH.
    Mol Endocrinol; 1988 Oct 15; 2(10):886-92. PubMed ID: 3185565
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.
    Lee ES, Schafer JM, Yao K, England G, O'Regan RM, De Los Reyes A, Jordan VC.
    Clin Cancer Res; 2000 Dec 15; 6(12):4893-9. PubMed ID: 11156249
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V, Jensen EV, Knabbe C.
    Cancer Res; 1998 Jan 15; 58(2):263-7. PubMed ID: 9443403
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.